Asthma is a
chronic disease that has a significant impact on quality of life and is particularly important in children and adolescents, in part due to the higher incidence of
allergies in children. The incidence of
asthma has increased dramatically during this time period, with the highest increases in the urban areas of developed countries. It seems that the incidence in developing countries may follow this trend as well. While our knowledge of the pathophysiology of
asthma and the available of newer, safer medication have both improved, the mortality of the disease has undergone an overall increase in the past 30 years.
Asthma treatment goals in children include decreasing mortality and improving quality of life. Specific treatment goals include but are not limited to decreasing
inflammation, improving lung function, decreasing clinical symptoms, reducing
hospital stays and emergency department visits, reducing work or school absences, and reducing the need for rescue medications. Non-pharmacological management strategies include
allergen avoidance, environmental evaluation for
allergens and irritants, patient education,
allergy testing, regular monitoring of lung function, and the use of
asthma management plans,
asthma control tests, peak flow meters, and
asthma diaries. Achieving
asthma treatment goals reduces direct and indirect costs of
asthma and is economically cost-effective. Treatment in children presents unique challenges in diagnosis and management. Challenges in diagnosis include consideration of other diseases such as viral respiratory illnesses or
vocal cord dysfunction. Challenges in management include evaluation of the child's ability to use
inhalers and peak flow meters and the management of
exercise-induced asthma.